Intelligence Β· Drug directory

FDA-Approved Drugs Directory

US FDA-approved and listed pharmaceutical products with Drugs@FDA-derived regulatory status, brand names, and pipeline cross-links.

Quick answer

FDA-approved drugs: NovaPharmaNews tracks 2,719 pharmaceutical drugs in this segment. US FDA-approved and listed pharmaceutical products with Drugs@FDA-derived regulatory status, brand names, and pipeline cross-links.

2,719 drugs Β· FDA approved Β· by data quality Β· Page 112 of 114

  1. ziprasidone hydrochloride

    ZIPRASIDONE HYDROCHLORIDE

    ORAL FDA: approved

  2. ziprasidone mesylate

    ZIPRASIDONE MESYLATE

    INTRAMUSCULAR FDA: approved

  3. ziv-aflibercept

    ZALTRAP

    INJECTION FDA: approved

  4. zolbetuximab-clzb

    VYLOY

    INJECTION FDA: approved

  5. zoliflodacin

    NUZOLVENCE

    ORAL FDA: approved

  6. zongertinib

    HERNEXEOS

    ORAL FDA: approved Β· NMPA: clinical trials

  7. zonisamide

    ZONEGRAN Amdipharm Mercury (Australia) Pty Limited

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved Β· PMDA: approved Β· NMPA: clinical trials

    N03AX15
  8. zuranolone

    ZURZUVAE

    ORAL FDA: approved Β· EMA: approved

    N06A
  9. adalimumab

    ABRILADA Pfizer Australia Pty Ltd

    FDA: approved Β· EMA: approved Β· TGA: approved Β· PMDA: approved Β· NMPA: clinical trials

    L04AB04
  10. asparaginase

    GRASPA

    FDA: approved Β· EMA: approved

    L01XX02
  11. botulinum toxin type b

    NEUROBLOC

    FDA: approved Β· EMA: withdrawn

    M03AX01
  12. infliximab

    INFLECTRA Pfizer Australia Pty Ltd

    FDA: approved Β· EMA: approved Β· TGA: approved Β· PMDA: approved Β· NMPA: clinical trials

    L04AB02
  13. inotuzumab ozogamicin

    BESPONSA Pfizer Australia Pty Ltd

    FDA: approved Β· EMA: approved Β· TGA: approved Β· PMDA: approved

    L01FB01
  14. interferon alfa-2b

    INTRONA

    FDA: approved Β· EMA: withdrawn

    L03AB05
  15. interferon beta-1a

    BIFERONEX

    FDA: approved Β· EMA: approved

    L03AB07
  16. lasmiditan

    RAYVOW

    FDA: approved Β· EMA: approved

    N02CC08
  17. nilotinib

    TASIGNA Novartis Pharmaceuticals

    FDA: approved Β· EMA: approved Β· TGA: approved

    L01EA03
  18. omalizumab

    OMLYCLO Novartis Pharmaceuticals

    FDA: approved Β· EMA: approved Β· TGA: approved Β· PMDA: approved

    R03DX05
  19. ozanimod

    ZEPOSIA Bristol-Myers Squibb Australia Pty Ltd

    FDA: approved Β· EMA: approved Β· TGA: approved

    L04AA38
  20. palivizumab

    SYNAGIS

    FDA: approved Β· EMA: approved

    J06BD01
  21. pegaspargase

    ONCASPAR

    FDA: approved Β· EMA: approved

    L01XX24
  22. pegfilgrastim

    PELGRAZ Accord Healthcare Pty.

    FDA: approved Β· EMA: approved Β· TGA: approved

    L03AA13
  23. peginterferon alfa-2b

    CYLATRON

    FDA: approved Β· EMA: withdrawn

    L03AB10
  24. reteplase

    ECOKINASE

    FDA: approved Β· EMA: withdrawn

    B01AD07

Frequently asked questions

How many fda approved drugs are listed?

2,719 drug profiles match this regulatory segment in our published index.

Where does approval data come from?

Profiles combine FDA Drugs@FDA, EMA EPAR references, and regional authority feeds. See our data sources page for attribution.